Clinical Trial: Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733037) titled 'Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia' on July 23.

Brief Summary: This is a randomized, double-blind, placebo-controlled phase 2 trial to evaluate the safety and efficacy in immune thrombocytopenia patients receiving fecal microbiota transplantation

Study Start Date: Jan. 10

Study Type: INTERVENTIONAL

Condition: Immune Thrombocytopenia (ITP)

Intervention: DRUG: Fecal microbiota transplantation

Patients in the fecal microbiota transplantation group receive bowel preparation and standard fecal microbiota capsules for 6 days. Those in the placebo group receive bowel preparatio...